CymitQuimica logo

Dihydroxy oxaliplatin-pt(IV)

CAS:

Ref. 3D-FD22061

2mg
305.00€
5mg
607.00€
10mg
1,036.00€
25mg
2,112.00€
50mg
3,168.00€
Dihydroxy oxaliplatin-pt(IV)
Biosynth

    Product Information

    Name:Dihydroxy oxaliplatin-pt(IV)
    Synonyms:
    • (OC-6-33)-[(1R,2R)-1,2-cyclohexanediamine-κN1,κN2][ethanedioato(2-)-κO1 ,κO2]dihydroxyplatinum[OC-6-33-(1R-trans)]-(1,2-cyclohexanediamine-N ,N')[ethanedioato(2-)-O,O']dihydroxyplatinum
    Brand:Biosynth
    Description:Dihydroxy oxaliplatin-pt(IV) is a fine chemical that belongs to the group of platinum-based chemotherapy drugs. It is an intermediate in the synthesis of oxaliplatin, a drug used in the treatment of colorectal cancer and other cancers. Dihydroxy oxaliplatin-pt(IV) is also a versatile building block for pharmaceuticals and research chemicals. This compound has been shown to be useful as a reaction component in organic synthesis and as a speciality chemical for lab use. Dihydroxy oxaliplatin-pt(IV) can be used as a reagent or intermediate in organic synthesis, including cross coupling reactions with alkenes, alkynes, amines, and thiols.
    Notice:Our products are intended for lab use only. For any other use, please contact us.

    Chemical properties

    Molecular weight:431.31 g/mol
    Formula:C8H16N2O6Pt
    Purity:Min. 95 Area-%
    Color/Form:Powder

    Technical inquiry about: Dihydroxy oxaliplatin-pt(IV)

    Please use instead the cart to request a quotation or an order

    If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.
    ◻️
    CYMIT QUÍMICA, S.L. as responsible for the treatment will treat your data in order to respond to your queries or requests. You can access, rectify and delete your data, as well as exercise other rights by consulting the additional and detailed information on data protection in our Web Privacy Policy.
    * Mandatory fields.